Roxbury Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$322K Buy
268
+1
+0.4% +$1.02K 0.25% 79
2026
Q1
$245K Buy
267
+3
+1% +$3.04K 0.22% 83
2025
Q4
$284K Buy
264
+24
+10% +$22.9K 0.26% 69
2025
Q3
$183K Buy
240
+53
+28% +$39.4K 0.17% 93
2025
Q2
$146K Buy
187
+77
+70% +$59.8K 0.14% 106
2025
Q1
$101K Buy
110
+1
+0.9% +$832 0.1% 123
2024
Q4
$87.4K Buy
+109
New +$90.3K 0.08% 124

Other funds holding LLY

Roxbury Financial's LLY Position: Q2 2026 in Review

Roxbury Financial increased its Eli Lilly (LLY) stake by 0.37% in Q2 2026, buying an estimated $1.02K and bringing the position to 268 shares worth $322K. The position accounts for 0.25% of the portfolio, ranked #79.

Roxbury Financial first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Roxbury Financial held 268 shares of Eli Lilly worth $322K as of Q2 2026.
  • Roxbury Financial bought 1 Eli Lilly share in Q2 2026, an estimated $1.02K.
  • Eli Lilly made up 0.25% of Roxbury Financial's portfolio in Q2 2026, its #79 holding.
  • Roxbury Financial first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Roxbury Financial's 13F filing for Q2 2026, filed 1 Jul 2026.